Companies / Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd.

NYSE: RGNTCIK 1912966OR AKIVA

Financials

Revenue—
Net income$-13.65M
Total debt$1.20M
Cash$7.38M
Diluted EPS$-24.16
Shares outstanding5.2M

Ownership

5.2M shares outstanding
100.0%Public float
Ownership
Public float100.00%5,179,378

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Alpert Susan PHD MDDirector
——
Ben-Elazar PiniDirector
——
Cohen-Arazi EfraimDirector
——
Dr. Ehud GellerCEOChief Executive Officer · Director
——
Dykan JeffDirector
——
Gon OriChief Financial Officer
——
Gordashnikov ArieChief Accounting Officer
——
Reske GalitChief Medical Officer
——
Valentine KeithDirector
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Dr. Ehud GellerPassive13G———